Cor Vasa 2012, 54(9-10):517-519

Antikoagulační léčba dabigatranem a nová doporučení Evropské kardiologické společnosti pro management fibrilace síní

MUDr. Petr Janský
Kardiochirurgická klinika, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Motol, Praha

Published: September 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janský P. Antikoagulační léčba dabigatranem a nová doporučení Evropské kardiologické společnosti pro management fibrilace síní. Cor Vasa. 2012;54(9-10):517-519.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. J. Heeringa, D.A. van der Kuip, A. Hofman, et al., Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study, European Heart Journal 27 (2006) 949-953. Go to original source... Go to PubMed...
    2. H.J. Lin, P.A. Wolf, M. Kelly-Hayes, et al., Stroke severity in atrial fibrillation. The Framingham Study, Stroke 27 (1996) 1760-1764. Go to original source... Go to PubMed...
    3. R.G. Hart, L.A. Pearce, M.I. Aguilar, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Annals of Internal Medicine 146 (2007) 857-867. Go to original source...
    4. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, et al. Newly identified events in the RE-LY trial, New England Journal of Medicine 363 (2010) 1875-1876. Go to original source... Go to PubMed...
    5. S.H. Hohnloser, J. Oldgren, S. Yang, et al., Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial, Circulation 125 (2012) 669-676. Go to original source... Go to PubMed...
    6. R. Nagarakanti, M.D. Ezekowitz, J. Oldgren, et al., Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion, Circulation 123 (2011) 131-136. Go to original source... Go to PubMed...
    7. A.J. Camm, G.Y. Lip, R. De Caterina, et al., 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association, European Heart Journal 2012 Aug 24. [Epub ahead of print]

    Return to the content